Laserfiche WebLink
C <br /> CHROMIC OXIDE <br /> 30 '130 <br /> 11 NEW <br /> Conditions to Avoid <br /> Exposure to moisture <br /> Incompatible Mat rim alas <br /> Strong oxidizing agents <br /> Hazardous Decomposltian Products <br /> At high temperatures,, unro+ mium {VI) Compounds <br /> Information on Ukely routes of ex osu a E_ <br /> Inhalation : May cause irritation of respiratory tract. <br /> Eye contact; Contact with eyes may cause irritation. <br /> Skin contact: Nonirritating to the skin . <br /> Not expected to cause adverse effects , 1 <br /> Ingestion : i; <br /> See below <br /> Product Information i <br /> ] <br /> component information : <br /> LDSolOral LD111 50/Dermal LC5011nhalation <br /> Components >5 .41 mgll 4 h (rat) <br /> Chromium (III) oxide > 5000 mglkg (rat) <br /> 1308-38.9 <br /> information on Toxicoi99i9AI Effects <br /> Dela a and mediate effects a§ well as chronic offecls from short an Ion •term ex osur <br /> Corrosivity : None , <br /> Sensitization: No sensitizing effects known <br /> Mutagenlc effects : None expected . Not regarded as mutagenic. <br /> Carcinogenic effects : Chromium and Chromium compounds has been reviewed by IARC , There is inadequate <br /> evidence In humans for the carcinogenicity of metallic chromium and chromium[,,,] <br /> compounds. There Is inadequate evidence for the carcinogenicity of metallic chromium and <br /> re) the <br /> that Metallic chromium um and chrounds In omium[lii] compoerimental undsha a noot classifiablenas to their concluded <br /> carcinogenicity to humans (Group 3) <br /> IARC NTP OSHA <br /> Components ACGIH Group 3- Unclassifiable <br /> Chromium (III) oxide <br /> 1308-38.9 as to Carcinogenicity to <br /> Humans (metallic <br /> chromium & <br /> chromium ill]) <br /> Reproductive Toxicity ; This product does not contain any known or suspected reproductive hazards <br /> Developmental Toxicity; None known. <br /> Chronic Toxicity <br /> Chronic toxicity * Prolonged or repeated inhalation may cause damage to the lungs <br /> III NEW <br /> Revision Number: 1 page 5 8 <br />